Premium
Tercica (MM) (TRCA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Tercica, Inc. (Nasdaq: TRCA) today announced financial results for the quarter ended June 30, 2008. Net product sales totaled $6.2 million, compared to $2.0 million in the...
Tercica, Inc. (NASDAQ: TRCA) today announced the first results from the Increlex? Growth Forum Database (IGFD) Registry in two posters presented at the 90th annual meeting of...
Tercica, Inc. (NASDAQ: TRCA) today announced that company management will present at the FBR Capital Markets 12th Annual Spring Investor Conference on Wednesday, May 28, 2008 at...
Tercica, Inc. (Nasdaq:TRCA) today announced financial results for the quarter ended March 31, 2008. Total net product sales totaled $4.3 million, compared to $1.1 million in the...
Tercica, Inc. (NASDAQ: TRCA) today announced the Company will release its 2008 first quarter financial results after market close on Monday, May 12, 2008. Management will...
Tercica, Inc. (Nasdaq: TRCA) today announced that company management will make the following investment community presentations: Cowen & Company 28th Annual Health Care...
Tercica, Inc. (NASDAQ:TRCA) today announced that it has named Richard King as President and Chief Operating Officer. Previously, Mr. King was Tercica?s Chief Operating Officer...
Tercica, Inc. (Nasdaq: TRCA) today announced financial results for the quarter and year ended December 31, 2007. Net product sales for the quarter ended December 31, 2007...
Tercica, Inc. (NASDAQ:TRCA) today announced the Company will release its 2007 fourth quarter and year-end financial results before market open on Wednesday, February 27, 2008...
Tercica, Inc. (NASDAQ: TRCA) today announced that the Company has begun dosing the first patient in a Phase II clinical study evaluating the combination of Genentech, Inc.?s...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
